JP2002521490A5 - - Google Patents

Download PDF

Info

Publication number
JP2002521490A5
JP2002521490A5 JP2000562395A JP2000562395A JP2002521490A5 JP 2002521490 A5 JP2002521490 A5 JP 2002521490A5 JP 2000562395 A JP2000562395 A JP 2000562395A JP 2000562395 A JP2000562395 A JP 2000562395A JP 2002521490 A5 JP2002521490 A5 JP 2002521490A5
Authority
JP
Japan
Prior art keywords
peptide
carrier
drug
base
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000562395A
Other languages
English (en)
Japanese (ja)
Other versions
JP5101764B2 (ja
JP2002521490A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/017351 external-priority patent/WO2000006599A1/en
Publication of JP2002521490A publication Critical patent/JP2002521490A/ja
Publication of JP2002521490A5 publication Critical patent/JP2002521490A5/ja
Application granted granted Critical
Publication of JP5101764B2 publication Critical patent/JP5101764B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000562395A 1998-07-30 1999-07-30 Hiv膜融合のインヒビター Expired - Fee Related JP5101764B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US9467698P 1998-07-30 1998-07-30
US60/094,676 1998-07-30
US10026598P 1998-09-14 1998-09-14
US60/100,265 1998-09-14
US10105898P 1998-09-18 1998-09-18
US60/101,058 1998-09-18
US13229599P 1999-05-03 1999-05-03
US60/132,295 1999-05-03
PCT/US1999/017351 WO2000006599A1 (en) 1998-07-30 1999-07-30 Inhibitors of hiv membrane fusion

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010045882A Division JP2010180217A (ja) 1998-07-30 2010-03-02 Hiv膜融合のインヒビター

Publications (3)

Publication Number Publication Date
JP2002521490A JP2002521490A (ja) 2002-07-16
JP2002521490A5 true JP2002521490A5 (https=) 2006-09-14
JP5101764B2 JP5101764B2 (ja) 2012-12-19

Family

ID=27492743

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000562395A Expired - Fee Related JP5101764B2 (ja) 1998-07-30 1999-07-30 Hiv膜融合のインヒビター
JP2010045882A Pending JP2010180217A (ja) 1998-07-30 2010-03-02 Hiv膜融合のインヒビター

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010045882A Pending JP2010180217A (ja) 1998-07-30 2010-03-02 Hiv膜融合のインヒビター

Country Status (6)

Country Link
EP (1) EP1100818B1 (https=)
JP (2) JP5101764B2 (https=)
KR (1) KR20010099605A (https=)
AU (1) AU770482B2 (https=)
CA (1) CA2338022C (https=)
WO (1) WO2000006599A1 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150088A (en) 1997-04-17 2000-11-21 Whitehead Institute For Biomedical Research Core structure of gp41 from the HIV envelope glycoprotein
US6841657B2 (en) 1997-04-17 2005-01-11 Whitehead Institute For Biomedical Research Inhibitors of HIV membrane fusion
US6818740B1 (en) 1997-04-17 2004-11-16 Whitehead Institute For Biomedical Research Inhibitors of HIV membrane fusion
US6747126B1 (en) 1998-07-30 2004-06-08 Whitehead Institute For Biomedical Research Peptide inhibitors of HIV entry
US7960504B2 (en) 1998-07-30 2011-06-14 Whitehead Institute For Biomedical Research Inhibitors of HIV membrane fusion
CA2395291C (en) 1999-12-16 2012-09-11 Whitehead Institute For Biomedical Research Five-helix protein
US6605427B2 (en) 2000-02-10 2003-08-12 Panacos Pharmaceuticals, Inc. Assay for detection of viral fusion inhibitors
US7199102B2 (en) 2000-08-24 2007-04-03 The Regents Of The University Of California Orally administered peptides synergize statin activity
US6664230B1 (en) * 2000-08-24 2003-12-16 The Regents Of The University Of California Orally administered peptides to ameliorate atherosclerosis
JP5180422B2 (ja) * 2000-09-22 2013-04-10 ホワイトヘッド インスチチュート フォアー バイオメディカル リサーチ Hiv浸入のペプチドインヒビター
KR100447943B1 (ko) * 2000-11-06 2004-09-08 한국과학기술연구원 Hiv의 감염 억제 펩타이드
CN1100564C (zh) * 2001-08-29 2003-02-05 周根发 用于治疗hiv感染的药物、其组合物及其用途
EP1438333A4 (en) * 2001-09-27 2005-10-19 Tibotec Pharm Ltd ANTI-FUSION TEST
WO2003029284A1 (en) * 2001-09-27 2003-04-10 Nobutaka Fujii Anti-hiv agent
EP1463521A4 (en) * 2001-12-17 2009-06-24 Us Gov Health & Human Serv INHIBITOR OF GP41
JP5069558B2 (ja) * 2004-06-01 2012-11-07 メルク・シャープ・エンド・ドーム・コーポレイション HIVgp41融合中間物質の安定したペプチド模倣薬
KR20070089996A (ko) 2004-12-06 2007-09-04 더 리전트 오브 더 유니버시티 오브 캘리포니아 세동맥의 구조 및 기능의 개선 방법
EP2005177B1 (en) * 2006-04-06 2013-07-10 Janssen R&D Ireland A homogeneous time resolved fluorescence based test method
CN104203276A (zh) * 2012-03-20 2014-12-10 默沙东公司 Hiv-1 gp41前发夹中间物的稳定肽模拟物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100358209B1 (ko) * 1992-07-20 2003-01-24 듀크 유니버시티 Hiv복제를저해하는조성물

Similar Documents

Publication Publication Date Title
JP2002521490A5 (https=)
AU725283B2 (en) Bioadhesive pharmaceutical composition for the controlled release of active principles
CA2293346A1 (en) Device and method for treatment of dysmenorrhea
NO20051964D0 (no) Terapeutiske blandinger for legemiddelavlevering til og gjennom dekkende epitel
ATE116131T1 (de) Mittel zur nichsystemischen verabreichung von sedativa und analgetika.
ES2249763T5 (es) Sistema de administracion transdermica de farmaco potente de flujo bajo.
JP2005517669A5 (https=)
JP2003505345A5 (https=)
JP2009261939A (ja) 安全性が改善されたコンドーム
NO20014859L (no) Raskt dispergerbare doseringsformer inneholdende fiskegelatin
JP2005536568A5 (https=)
JP2007525461A5 (https=)
CO5680109A1 (es) Compuestos para el tratamiento de la disfuncion sexual femenina
JP2000026284A (ja) 経皮ドラッグデリバリ―のための固体マトリックスシステム
HUP9802913A2 (hu) Bioadhezív, szilárd gyógyszer-adagolási forma
NO20043871L (no) Legemiddelformuleringer med kontrollert frigjoring som inneholder et baererpeptid
EP0280737A4 (en) Steroidal drug-containing preparation for external use.
BR0007360A (pt) Composição de liberação controlada
TWI222368B (en) Intraoral adhesive preparation
EP0873751A3 (en) Pharmaceutical product for application to uterus mucosa
AR242109A1 (es) Dispositivo para fijar un dispositivo contraceptivo a la pared del utero, particularmente en el periodo inmediatamente posterior al parto.
NZ509031A (en) A disk formed from a filmogenic polymer carrying a therapeutic agent selected from a stabiliser, a solubiliser, an enhancer and a plasticiser
JP2002080348A (ja) 口腔内貼付製剤
JP2003511403A5 (https=)
ATE326199T1 (de) Vorrichtung zur gleichzeitigen austragung von wirkstoffen in den cervikal- und vaginalkanal